This monoclonal antibody for KSHV ORF26 (capsid) has been developed using ORF26 protein as an antigen and has demonstrated broad applicability in helping to discern distinct subpopulations of KSHV associated viral particles at various stages of virion assembly.
| Inventor | Institute |
|---|---|
| Fanxiu Zhu | Florida State University Research Foundation |
| Cat. #: | 160640 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Genetics;Microbiology |
| Application: | WB |
| Target: | Open Reading Frame 26 |
| Reactivity: | Other Species |
| Host: | Mouse |
| Class: | Monoclonal |
| Product description: | Kaposi's sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi's sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be associated with two lymphoproliferative diseases (Fu et al., 2015). ORF26 (capsid) is a gene associated with the late lytic viral life cycle of KSHV. This monoclonal antibody for KSHV ORF26 (capsid) has been developed using ORF26 protein as an antigen and has demonstrated broad applicability in helping to discern distinct subpopulations of KSHV associated viral particles at various stages of virion assembly. |
|---|---|
| Conjugation: | Unconjugated |
| Isotype: | IgG |
| Immunogen: | ORF26 protein |
| Target background: | Kaposi's sarcoma-associated herpesvirus (KSHV) has been identified as the causative agent of Kaposi's sarcoma, the most common malignancy in HIV-infected individuals. KSHV has also been shown to be be associated with two lymphoproliferative diseases (Fu et al., 2015).ORF26 (capsid) is a gene associated with the late lytic viral life cycle of KSHV. This monoclonal antibody for KSHV ORF26 (capsid) has been developed using ORF26 protein as an antigen and has demonstrated broad applicability in helping to discern distinct subpopulations of KSHV associated viral particles at various stages of virion assembly. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Fu et al. 2015. J Virol. 89(1):195-207. PMID: 25320298. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151030 | Anti-Progesterone [11P14] |
Key Info
Anti-Progesterone [11P14]
|
View Tool | |||||||||||||||||||
| 151026 | Anti-FCGR1 [10.1] mAb |
Key Info
Anti-FCGR1 [10.1] mAb
|
View Tool | |||||||||||||||||||
| 151027 | Anti-HSVICP8 [10A3] |
Key Info
Anti-HSVICP8 [10A3]
|
View Tool | |||||||||||||||||||
| 151028 | Anti-Cytochrome P450 2C2, 2B1/2 [h7] |
Key Info
Anti-Cytochrome P450 2C2, 2B1/2 [h7]
|
View Tool | |||||||||||||||||||
| 151018 | Anti-Mos [R38.1] |
Key Info
Anti-Mos [R38.1]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.